With a surge in high-value acquisitions in the wellness industry, major consumer brands are significantly increasing investments, most notably with Procter & Gamble’s $3.8 billion acquisition of supplement producer Thorne.
During 2026, the pace of mergers and purchases in the health and wellness sector has accelerated as top consumer packaged goods (CPG) companies pursue scientifically backed brands to keep up with evolving consumer demand. A prime example is Procter & Gamble’s (P&G) agreement to acquire Thorne, which highlights the strategic shift toward products supporting longevity and advanced functional health. This change is fueled in part by higher use of GLP-1 weight-loss medications as consumers seek improved nutritional solutions and targeted supplementation.
The Thorne Deal and Industry Trends
The Thorne acquisition by P&G, totaling $3.8 billion, follows several transitions for the supplements company. Thorne, established in 1984, went public in 2021, only to be bought out and taken private by L Catterton for $680 million. In its most recent financial disclosures, Thorne announced that its 2025 revenue topped $500 million.
Earlier in the year, the sector saw Unilever buy Grüns, a three-year-old firm specializing in gummy multivitamins, for an undisclosed price. These developments underscore a broader movement within the CPG industry toward acquiring wellness brands recognized for scientific innovation and credibility.
Commenting on these shifts, Mike Ross, U.S. consumer markets deals leader at PwC, observed, “CPG companies are making more deliberate choices about what fits within their portfolios and, equally, what doesn’t.” He noted brands must align more closely with rising demand for high-protein, fiber-dense, and hydration-focused products—especially as GLP-1 drug consumption rises. Ross also indicated that companies are divesting from less compatible brands, favoring those with a strong scientific wellness foundation.
Strategic Shifts and Consumer Behavior
Brands offering functional health, longevity support, and nutrition tailored to GLP-1 users now stand at the forefront of acquisition strategies. Ross highlighted that these preferences represent long-lasting consumer shifts rather than passing trends. Drawing from a recent PwC report, he emphasized how U.S. adoption of GLP-1 weight-loss medications has increased quickly, with usage doubling over the last 18 months. Moreover, according to the report, 80% of current and 74% of former GLP-1 users say they must use several products to maintain their health regimens.
Outstanding revenue growth and prominent performance in e-commerce, pharmacy, and wholesale club channels increase a wellness brand’s acquisition appeal among major buyers. High-value brands place a premium on “first-party consumer data,” Ross mentioned, particularly as artificial intelligence reshapes product discovery and purchasing behavior. “Where a brand appears—whether through an AI-powered suggestion, a social feed, or a recurring subscription—now matters more than just physical shelf space,” Ross explained.
Challenges in Nutrition and the M&A Outlook
Rachel Hirsch, founder and managing partner at Wellness Growth Ventures, offered insight into the underlying drivers for the spate of wellness mergers and acquisitions: “Modern history has never faced a period of such severe nutrient deficiency,” she asserted, attributing it to diminishing affordability and availability of natural foods. Hirsch believes the combination of high processed food consumption and widespread GLP-1 use will increase the need for supplementation. “Increased demand leads to more M&A activity,” she commented.
She further explained that the emergence of billion-dollar deals indicates a changing landscape in supplements: “The direction now is more supplementation, not less.” As certain brands become part of everyday health regimes, strategic buyers are prepared to pay significant premiums for high-performing, trusted assets, according to Hirsch.
The heightened focus of major consumer brands on nutrition science and wellness marks a dramatic shift in the industry. Continued robust M&A activity suggests a lasting transformation, establishing wellness brands as foundational contributors to addressing consumers’ changing health needs.